1
|
Jomehzadeh N, Moosavian M, Saki M and
Rashno M: Legionella and legionnaires' disease: An overview.
J Acute Dis. 8:221–232. 2019.
|
2
|
Engel MF, Van Manen L, Hoepelman AIM,
Thijsen S and Oosterheert JJ: Diagnostic, therapeutic and economic
consequences of a positive urinary antigen test for
Legionella spp. in patients admitted with community-acquired
pneumonia: A 7-year retrospective evaluation. J Clin Pathol.
66:797–802. 2013.PubMed/NCBI View Article : Google Scholar
|
3
|
Brady MF and Sundareshan V: Legionnaires'
Disease (Legionella Infection); StatPearls Publishing,
2018.
|
4
|
Tossa P, Deloge-Abarkan M, Zmirou-Navier
D, Hartemann P and Mathieu L: Pontiac fever: An operational
definition for epidemiological studies. BMC Public Health.
6(112)2006.PubMed/NCBI View Article : Google Scholar
|
5
|
United States Department of Labor:
Occupational Safety and Health Administration: Legionellosis
(Legionnaires' Disease and Pontiac Fever). https://www.osha.gov/legionnaires-disease. Accessed
September 29, 2022.
|
6
|
Centers for Disease Control and Prevention
(CDC): Legionella (Legionnaires' Disease and Pontiac Fever):
History, Burden, and Trends. https://www.cdc.gov/legionella/about/history.html.
Accessed September 29, 2022.
|
7
|
European Centre for Disease Prevention and
Control (ECDC): Annual Epidemiological Report for 2020:
Legionnaires' disease. https://www.ecdc.europa.eu/en/publications-data/legionnaires-disease-annual-epidemiological-report-2020.
Accessed September 29, 2022.
|
8
|
Rota MC, Caporali MG, Bella A, Scaturro M,
Giannitelli S and Ricci ML: Istituto Superiore di Sanità nazionale
e bollettino epidemiologico b n I risultati del sistema di
sorveglianza della legionellosi in Italia nel 2020 durante la
pandemia di COVID-19. Vol 2. 2021.
|
9
|
Cosentino F, Moscatt V, Marino A,
Pampaloni A, ScuderI D, Ceccarelli M, Benanti F, Gussio M, Larocca
L, Boscia V, et al: Clinical characteristics and predictors of
death among hospitalized patients infected with SARS-CoV-2 in
Sicily, Italy: A retrospective observational study. Biomed Rep.
16(34)2022.PubMed/NCBI View Article : Google Scholar
|
10
|
Musso N, Maugeri JG, Bongiorno D,
Stracquadanio S, Bartoloni G, Stefani S and Di Stefano ED:
SARS-CoV-2's high rate of genetic mutation under immune selective
pressure: From oropharyngeal B.1.1.7 to intrapulmonary B.1.533 in a
vaccinated patient. Int J Infect Dis. 118:169–172. 2022.PubMed/NCBI View Article : Google Scholar
|
11
|
García MT, Pelaz C, Giménez MJ and Aguilar
L: In vitro activities of gemifloxacin versus five quinolones and
two macrolides against 271 Spanish isolates of Legionella
pneumophila: Influence of charcoal on susceptibility test
results. Antimicrob Agents Chemother. 44:2176–2178. 2000.PubMed/NCBI View Article : Google Scholar
|
12
|
Brenner DJ, Steigerwalt AG, Epple P, Bibb
WF, McKinney RM, Starnes RW, Colville JM, Selander RK, Edelstein PH
and Moss CW: Legionella pneumophila serogroup Lansing 3
isolated from a patient with fatal pneumonia, and descriptions of
L. pneumophila subsp. pneumophila subsp. nov., L. pneumophila
subsp. fraseri subsp. nov., and L. pneumophila subsp. pascullei
subsp. nov. J Clin Microbiol. 26:1695–1703. 1988.PubMed/NCBI View Article : Google Scholar
|
13
|
Kim P, Deshpande A and Rothberg MB:
Urinary antigen testing for respiratory infections: Current
perspectives on utility and limitations. Infect Drug Resist.
15:2219–2228. 2022.PubMed/NCBI View Article : Google Scholar
|
14
|
Avni T, Bieber A, Green H, Steinmetz T,
Leibovici L and Paul M: Diagnostic accuracy of PCR alone and
compared to urinary antigen testing for detection of
Legionella spp: A systematic review. J Clin Microbiol.
54:401–411. 2016.PubMed/NCBI View Article : Google Scholar
|
15
|
European Committee on Antimicrobial
Susceptibility Testing (EUCAST): Antimicrobial susceptibility
testing of Legionella pneumophila. In: EUCAST. Guidance
document on Legionella. EUCAST, Växjö, 2016.
|
16
|
Rota MC, Caporali MG, Bella A, Scaturro M,
Giannitelli S and Ricci ML: I risultati del sistema di sorveglianza
della legionellosi in Italia nel 2020 durante la pandemia di
COVID-19. Boll Epidemiol Naz. 2:9–16. 2021.
|
17
|
European Centre for Disease Prevention and
Control (ECDC): Legionnaires’ disease. In: ECDC. Annual
epidemiological report for 2019. ECDC, Stockholm, 2021.
|
18
|
Williams A and Lever MS: Characterisation
of Legionella pneumophila antigen in urine of guinea pigs
and humans with Legionnaires' disease. J Infect. 30:13–16.
1995.PubMed/NCBI View Article : Google Scholar
|
19
|
Kawasaki T, Nakagawa N, Murata M, Yasuo S,
Yoshida T, Ando K, Okamori S and Okada Y: Diagnostic accuracy of
urinary antigen tests for legionellosis: A systematic review and
meta-analysis. Respir Investig. 60:205–214. 2022.PubMed/NCBI View Article : Google Scholar
|
20
|
McDade JE: Legionella and the
prevention of legionellosis. Emerg Infect Dis. 14:1006a–1006.
2008.
|
21
|
Pierre DM, Baron J, Yu VL and Stout JE:
Diagnostic testing for Legionnaires' disease. Ann Clin Microbiol
Antimicrob. 16(59)2017.PubMed/NCBI View Article : Google Scholar
|
22
|
Essig A, von Baum H, Gonser T, Haerter G
and Lück C: Microbiological diagnosis and molecular typing of
Legionella strains during an outbreak of legionellosis in
Southern Germany. Int J Med Microbiol. 306:109–114. 2016.PubMed/NCBI View Article : Google Scholar
|
23
|
Mercante JW and Winchell JM: Current and
emerging Legionella diagnostics for laboratory and outbreak
investigations. Clin Microbiol Rev. 28:95–133. 2015.PubMed/NCBI View Article : Google Scholar
|
24
|
Viasus D, Gaia V, Manzur-Barbur C and
Carratalà J: Legionnaires' Disease: Update on diagnosis and
treatment. Infect Dis Ther. 11:973–986. 2022.PubMed/NCBI View Article : Google Scholar
|
25
|
Robert S, Lhommet C, Brun CL, Garot D,
Legras A, Mankikian J and Goudeau A: Diagnostic performance of
multiplex PCR on pulmonary samples versus nasopharyngeal aspirates
in community-acquired severe lower respiratory tract infections. J
Clin Virol. 108:1–5. 2018.PubMed/NCBI View Article : Google Scholar
|
26
|
Ricci ML, Grottola A, Serpini GF, Bella A,
Rota MC, Frascaro F, Pegoraro E, Meacci M, Fabio A, Vecchi E, et
al: Improvement of legionnaires' disease diagnosis using real-time
PCR assay: A retrospective analysis, Italy, 2010 to 2015.
Eurosurveillance. 23(1800032)2018.PubMed/NCBI View Article : Google Scholar
|
27
|
Metlay JP, Waterer GW, Long AC, Anzueto A,
Brozek J, Crothers K, Cooley LA, Dean NC, Fine MJ, Flanders SA, et
al: Diagnosis and treatment of adults with community-acquired
pneumonia. An official clinical practice guideline of the American
thoracic society and infectious diseases society of America. Am J
Respir Crit Care Med. 200:e45–e67. 2019.PubMed/NCBI View Article : Google Scholar
|
28
|
Menéndez R, Torres A, Aspa J, Capelastegui
A, Prat C and de Castro FR: Community acquired pneumonia. New
guidelines of the Spanish society of chest diseases and thoracic
surgery (SEPAR). Arch Bronconeumol. 46:543–558. 2010.PubMed/NCBI View Article : Google Scholar
|
29
|
Losier A and Cruz CS: New testing
guidelines for community-acquired pneumonia. Curr Opin Infect Dis.
35:128–132. 2022.PubMed/NCBI View Article : Google Scholar
|
30
|
Kim J, Park S, Yang E, Kim H, Seo H, Chung
H, Jung J, Kim MJ, Chong YP, Lee SO, et al: Clinical features of
patients with Legionnaires disease showing initial clinical
improvement but radiological deterioration: A retrospective
single-center analysis. Medicine (Baltimore).
100(e28402)2021.PubMed/NCBI View Article : Google Scholar
|
31
|
Nakanishi M, Shiroshita A, Nakashima K,
Takeshita M, Kiguchi T and Yamada H: Clinical and computed
tomographic features of Legionella pneumonia with negative
urine antigen test results. Respir Investig. 59:204–211.
2021.PubMed/NCBI View Article : Google Scholar
|
32
|
Rajasurya V and Surani S: Legionnaires
disease in immunocompromised host. In: hospital acquired infection
and Legionnaires' disease. Surani S (ed). IntechOpen, London,
2020.
|
33
|
Marino A, Zafarana G, Ceccarelli M,
Cosentino F, Moscatt V, Bruno G, Bruno R, Benanti F, Cacopardo B
and Celesia BM: Immunological and clinical impact of DAA-mediated
HCV eradication in a cohort of HIV/HCV coinfected patients:
Monocentric Italian experience. Diagnostics (Basel).
11(2336)2021.PubMed/NCBI View Article : Google Scholar
|
34
|
Micali C, Russotto Y, Facciolà A, Marino
A, Celesia BM, Pistarà E, Caci G, Nunnari G, Pellicanò GF and Rullo
EV: Pulmonary kaposi sarcoma without respiratory symptoms and skin
lesions in an HIV-naïve patient: A case report and literature
review. Infect Dis Rep. 14:228–242. 2022.PubMed/NCBI View Article : Google Scholar
|
35
|
Marino A, Caltabiano E, Zagami A, Onorante
A, Zappalà C, Locatelli ME, Pampaloni A, Scuderi D, Bruno R and
Cacopardo B: Rapid emergence of cryptococcal fungemia,
Mycobacterium chelonae vertebral osteomyelitis and gastro
intestinal stromal tumor in a young HIV late presenter: A case
report. BMC Infect Dis. 18(693)2018.PubMed/NCBI View Article : Google Scholar
|
36
|
Marino A, Munafò A, Augello E, Bellanca
CM, Bonomo C, Ceccarelli M, Musso N, Cantarella G, Cacopardo B and
Bernardini R: Sarilumab administration in COVID-19 patients:
Literature review and considerations. Infect Dis Rep. 14:360–371.
2022.PubMed/NCBI View Article : Google Scholar
|
37
|
Edelstein PH and Cianciotto NP:
Legionella species and Legionnaires' Disease. The
Prokaryotes; Springer, New York, NY, 2006; pp. 988-1033.
|
38
|
Fernández JA, López P, Orozco D and Merino
J: Clinical study of an outbreak of Legionnaire's disease in Alcoy,
Southeastern Spain. Eur J Clin Microbiol Infect Dis. 21:729–735.
2002.PubMed/NCBI View Article : Google Scholar
|
39
|
Gacouin A, Le Tulzo Y, Lavoue S, Camus C,
Hoff J, Bassen R, Arvieux C, Heurtin C and Thomas R: Severe
pneumonia due to Legionella pneumophila: Prognostic factors,
impact of delayed appropriate antimicrobial therapy. Intensive Care
Med. 28:686–691. 2002.PubMed/NCBI View Article : Google Scholar
|
40
|
Heath CH, Grove DI and Looke DF: Delay in
appropriate therapy of Legionella pneumonia associated with
increased mortality. Eur J Clin Microbiol Infect Dis. 15:286–290.
1996.PubMed/NCBI View Article : Google Scholar
|
41
|
Falcone M, Russo A, Tiseo G, Cesaretti M,
Guarracino F and Menichetti F: Predictors of intensive care unit
admission in patients with Legionella pneumonia: Role of the
time to appropriate antibiotic therapy. Infection. 49:321–325.
2021.PubMed/NCBI View Article : Google Scholar
|
42
|
Woodhead M, Blasi F, Ewig S, Garau J,
Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der
Heijden G, et al: Guidelines for the management of adult lower
respiratory tract infections-full version. Clin Microbiol Infect.
17:E1–E59. 2011.PubMed/NCBI View Article : Google Scholar
|
43
|
Jasper AS, Musuuza JS, Tischendorf JS,
Stevens VW, Gamage SD, Osman F and Safdar N: Are fluoroquinolones
or macrolides better for treating Legionella pneumonia? A
systematic review and meta-analysis. Clin Infect Dis. 72:1979–1989.
2021.PubMed/NCBI View Article : Google Scholar
|
44
|
Kato H, Hagihara M, Asai N, Shibata Y,
Koizumi Y, Yamagishi Y and Mikamo H: Meta-analysis of
fluoroquinolones versus macrolides for treatment of
Legionella pneumonia. J Infect Chemother. 27:424–433.
2021.PubMed/NCBI View Article : Google Scholar
|
45
|
Martin SJ, Pendland SL, Chen C,
Schreckenberger P and Danziger LH: In vitro synergy testing of
macrolide-quinolone combinations against 41 clinical isolates of
Legionella. Antimicrob Agents Chemother. 40:1419–1421.
1996.PubMed/NCBI View Article : Google Scholar
|
46
|
Bivona DA, Mirabile A, Bonomo C, Bonacci
PG, Stracquadanio S, Marino A, Campanile F, Bonaccorso C, Fortuna
CG, Stefani S, et al: Heteroaryl-ethylenes as new effective agents
for high priority gram-positive and gram-negative bacterial
clinical isolates. Antibiotics (Basel). 11(767)2022.PubMed/NCBI View Article : Google Scholar
|
47
|
Tansarli GS and Mylonakis E: Systematic
review and meta-analysis of the efficacy of short-course antibiotic
treatments for community-acquired pneumonia in adults. Antimicrob
Agents Chemother. 62:e00635–e00618. 2018.PubMed/NCBI View Article : Google Scholar
|